Metal based therapeutics are a precious class of drugs in oncology research that include
examples of theranostic drugs, which are active in both diagnostic, specifically imaging, and …

GLOBOCAN 2012 estimates 14.1 million new cancer cases and 8.2 million cancer-related
deaths worldwide. Cancer is rapidly becoming a major public health concern in India as …

We report the synthesis, characterization, and antiproliferative activity of organo-osmium (II)
and organo-ruthenium (II) half-sandwich complexes [(η6-p-cym) Os (L) Cl] Cl (1 and 2) and …

In this work, the acridine nucleus was used as a lead-compound for structural modification
by adding different substituted thiosemicarbazide moieties. Eight new (Z)-2-(acridin-9 …

Here, we present a study on the synthesis and biological properties of the ruthenium
complexes having naphthyl substituted NHC ligands, which are of great importance for drug …

We report on the synthesis of novel Ru (II) compounds (Ru-1 to Ru-8) bearing R-pdc, 4-Cl-
pbinh ligands (where R= 4-CF 3, 4-F, 4-OH pdc= 3-phenyl-5-(1H-pyrrol-2-yl)-4, 5-dihydro …

In the current study, organoruthenium (II)-arene complexes (I-IV) have been prepared by the
reaction of [{(η 6-p-cym) RuCl} 2 (μ-Cl) 2] with new thiosemicarbazones (TSC1–4). The …

Although there are various treatment options for cancer, this disease still has caused an
increasing number of deaths, demanding more efficient, selective and less harmful drugs …

The organometallic arene ruthenium complexes are rapidly advancing. In particular, the
organoruthenium complexes of the type [(η6-arene) Ru (X)(Y)(Z)] have attracted increasing …

Ruthenium (II) polypyridyl complexes have drawn growing attention due to their
photophysical properties and anticancer activity. Herein we report four ruthenium (II) …